Your browser doesn't support javascript.
loading
The American Cancer Society National Lung Cancer Roundtable strategic plan: Implementation of high-quality lung cancer screening.
Fathi, Joelle T; Barry, Angela M; Greenburg, Grant M; Henschke, Claudia I; Kazerooni, Ella A; Kim, Jane J; Mazzone, Peter J; Mulshine, James L; Pyenson, Bruce S; Shockney, Lillie D; Smith, Robert A; Wiener, Renda Soylemez; White, Charles S; Thomson, Carey C.
Afiliación
  • Fathi JT; Department of Biobehavioral Nursing and Health Informatics, School of Nursing, University of Washington, Seattle, Washington, USA.
  • Barry AM; GO2 for Lung Cancer, Washington, District of Columbia, USA.
  • Greenburg GM; GO2 for Lung Cancer, Washington, District of Columbia, USA.
  • Henschke CI; Department of Family Medicine, Lehigh Valley Health Network, Allentown, Pennsylvania, USA.
  • Kazerooni EA; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Kim JJ; Phoenix Veterans Health Care System, Phoenix, Arizona, USA.
  • Mazzone PJ; Department of Radiology, Michigan Medicine/University of Michigan, Ann Arbor, Michigan, USA.
  • Mulshine JL; Department of Internal Medicine, Michigan Medicine/University of Michigan, Ann Arbor, Michigan, USA.
  • Pyenson BS; Department of Veterans Affairs, National Center for Health Promotion and Disease Prevention, Durham, North Carolina, USA.
  • Shockney LD; Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Smith RA; Department of Internal Medicine, Rush University Medical College, Chicago, Illinois, USA.
  • Wiener RS; Milliman, Inc, New York, New York, USA.
  • White CS; Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Thomson CC; Center for Early Cancer Detection Science, American Cancer Society, Atlanta, Georgia, USA.
Cancer ; 2024 Sep 20.
Article en En | MEDLINE | ID: mdl-39302235
ABSTRACT
More than a decade has passed since researchers in the Early Lung Cancer Action Project and the National Lung Screening Trial demonstrated the ability to save lives of high-risk individuals from lung cancer through regular screening by low dose computed tomography scan. The emergence of the most recent findings in the Dutch-Belgian lung-cancer screening trial (Nederlands-Leuvens Longkanker Screenings Onderzoek [NELSON]) further strengthens and expands on this evidence. These studies demonstrate the benefit of integrating lung cancer screening into clinical practice, yet lung cancer continues to lead cancer mortality rates in the United States. Fewer than 20% of screen eligible individuals are enrolled in lung cancer screening, leaving millions of qualified individuals without the standard of care and benefit they deserve. This article, part of the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) strategic plan, examines the impediments to successful adoption, dissemination, and implementation of lung cancer screening. Proposed solutions identified by the ACS NLCRT Implementation Strategies Task Group and work currently underway to address these challenges to improve uptake of lung cancer screening are discussed. PLAIN LANGUAGE

SUMMARY:

The evidence supporting the benefit of lung cancer screening in adults who previously or currently smoke has led to widespread endorsement and coverage by health plans. Lung cancer screening programs should be designed to promote high uptake rates of screening among eligible adults, and to deliver high-quality screening and follow-up care.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos